<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Cell therapy clinical trials 2009 &#8211; part III</title>
	<atom:link href="http://hematopoiesis.info/2009/08/22/cell-therapy-clinical-trials-2009-part-iii/feed/" rel="self" type="application/rss+xml" />
	<link>http://hematopoiesis.info/2009/08/22/cell-therapy-clinical-trials-2009-part-iii/</link>
	<description>Blood Stem Cell &#38; Cell Therapy Trends</description>
	<lastBuildDate>Mon, 14 May 2012 16:25:58 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
	<item>
		<title>By: Alex</title>
		<link>http://hematopoiesis.info/2009/08/22/cell-therapy-clinical-trials-2009-part-iii/#comment-11813</link>
		<dc:creator>Alex</dc:creator>
		<pubDate>Mon, 07 Sep 2009 21:09:49 +0000</pubDate>
		<guid isPermaLink="false">http://hematopoiesis.info/?p=786#comment-11813</guid>
		<description>Thanks Mohan,
Yes it was great study. I highlighted it in &lt;a href=&quot;http://hematopoiesis.info/2009/04/28/cell-therapy-clinical-trials-2009-part-ii/&quot; rel=&quot;nofollow&quot;&gt;2nd issue of &quot;cell Therapy clinical trials 2009&quot;&lt;/a&gt;.</description>
		<content:encoded><![CDATA[<p>Thanks Mohan,<br />
Yes it was great study. I highlighted it in <a href="http://hematopoiesis.info/2009/04/28/cell-therapy-clinical-trials-2009-part-ii/" rel="nofollow">2nd issue of &#8220;cell Therapy clinical trials 2009&#8243;</a>.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Mohan  C. Vemuri</title>
		<link>http://hematopoiesis.info/2009/08/22/cell-therapy-clinical-trials-2009-part-iii/#comment-11808</link>
		<dc:creator>Mohan  C. Vemuri</dc:creator>
		<pubDate>Fri, 04 Sep 2009 21:22:28 +0000</pubDate>
		<guid isPermaLink="false">http://hematopoiesis.info/?p=786#comment-11808</guid>
		<description>Alex - really great job.  

A recent publication in JAMA (April 15, 2009)highlighted on clinical trail results on Type 1 diabetes mellitus, following autologous nonmyeloablative Hematopoietic Stem cell transplantation, in 29.8 month follow up study.  This study achieved insulin independence as well the patients achieved significant C-peptide levels.  It might be a worth addition to Alex&#039;s compiled list</description>
		<content:encoded><![CDATA[<p>Alex &#8211; really great job.  </p>
<p>A recent publication in JAMA (April 15, 2009)highlighted on clinical trail results on Type 1 diabetes mellitus, following autologous nonmyeloablative Hematopoietic Stem cell transplantation, in 29.8 month follow up study.  This study achieved insulin independence as well the patients achieved significant C-peptide levels.  It might be a worth addition to Alex&#8217;s compiled list</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Alex</title>
		<link>http://hematopoiesis.info/2009/08/22/cell-therapy-clinical-trials-2009-part-iii/#comment-11785</link>
		<dc:creator>Alex</dc:creator>
		<pubDate>Thu, 27 Aug 2009 13:13:37 +0000</pubDate>
		<guid isPermaLink="false">http://hematopoiesis.info/?p=786#comment-11785</guid>
		<description>I&#039;d agree in general. 
Unfortunately results from different groups frequently different. So, we don&#039;t have many conclusive data, based on clinical trials results.
Recent findings from long-term follow-up fetal neurotransplantation is not good. Even most trials indicated short-term improvement. 
Cancer vaccines also doing so so. Expectations a while ago were much greater then results we got.
Tolerance induction is sounds great!</description>
		<content:encoded><![CDATA[<p>I&#8217;d agree in general.<br />
Unfortunately results from different groups frequently different. So, we don&#8217;t have many conclusive data, based on clinical trials results.<br />
Recent findings from long-term follow-up fetal neurotransplantation is not good. Even most trials indicated short-term improvement.<br />
Cancer vaccines also doing so so. Expectations a while ago were much greater then results we got.<br />
Tolerance induction is sounds great!</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Mr. Gunn</title>
		<link>http://hematopoiesis.info/2009/08/22/cell-therapy-clinical-trials-2009-part-iii/#comment-11779</link>
		<dc:creator>Mr. Gunn</dc:creator>
		<pubDate>Wed, 26 Aug 2009 19:20:35 +0000</pubDate>
		<guid isPermaLink="false">http://hematopoiesis.info/?p=786#comment-11779</guid>
		<description>Thanks for compiling this summary, Alexey. The tolerance induction work is pretty interesting, the cancer vaccine work is coming along, but the neural stuff still seems like it&#039;s struggling to make significant headway.  Would you agree?</description>
		<content:encoded><![CDATA[<p>Thanks for compiling this summary, Alexey. The tolerance induction work is pretty interesting, the cancer vaccine work is coming along, but the neural stuff still seems like it&#8217;s struggling to make significant headway.  Would you agree?</p>
]]></content:encoded>
	</item>
</channel>
</rss>

